Rich Nelson, Senior Manager, Global Logistics for Clinical Services at PCI, will be presenting the company's expertise at Clinical Trial Supply West Coast 2019. The two-day conference will be held on 14-15 May in Burlingame, California.
Nelson will share PCI’s significant experience, providing an overview of the differences and potential difficulties involved with the global movement of scheduled drugs. He will also discuss the impact of those processes on timelines and logistics plans for clinical trials.
Clinical trials insight
In his role with PCI, Rich works with clients to provide seamless global distribution for their investigational drug products, ensuring cost-effective and time-efficient delivery throughout the clinical trials process.
Nelson explained: “The process of handling scheduled drugs is highly complex, due to the inherent risks involved with the product, and the need for absolute compliance in its development, manufacturing and distribution. PCI has a long-standing track record of supporting clients across the world in this challenging area, and I am delighted to have the opportunity to share some of our insight and experience at the CTS West Coast event."
Focusing on ‘Scheduled Drug – Processes and Complications in Global Logistics’, PCI’s Nelson, presentation is on day one at 9 am PDT.
Global footprint
PCI recently announced the expansion of its global controlled substance infrastructure, coinciding with new legislation from the US government in addressing concerns about the nations’ opioid crisis. The company offers expertise in packaging and logistics for controlled substances, approved for Schedule I – V DEA designations.
A biopharmaceutical outsourcing services provider, PCI is a trusted partner for the global healthcare industry and has been providing development solutions that increase client’s products' speed to market and opportunities for commercial success.
PCI’s domestic operations are located in Philadelphia, PA, Rockford, IL, and San Diego, CA, complemented by operations in the UK, Ireland and Australia.
